| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.00015 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 7.5e-05 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.013 | 1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |